COVID-19 Information

For CAP-Accredited Laboratories

  • The College of American Pathologists is advocating for pathologists and laboratories in the wake of the outbreak of the novel (new) coronavirus “SARS-CoV-2” and the disease it causes, “coronavirus disease 2019” (abbreviated “COVID-19”).
  • Mandatory Test Result Reporting for SARS-CoV-2 (COVID-19). The Centers for Medicare and Medicaid Services (CMS) memorandum, QS0-20-37-CLIA, announces updates to the Clinical Laboratory Improvement Amendments (CLIA) that are defined in the interim final rule CMS-3410-IFC. The rule imposes new requirements on laboratories for reporting SARS-CoV-2 test results during the public health emergency.
  • The CAP is recommending a modified inspection process to adapt to the current climate in health care and to provide for increased safety measures. Learn more about our recommended pre-inspection document review step and our 2020 Modified Inspections Toolkit.
  • PrimeStore® MTM Releases Cyanide Gas When Exposed to Bleach. CMS and CDC share alert regarding PrimeStore® Molecular Transport Medium (MTM) – an approved transport media for COVID-19 diagnostic swab samples – advising it contains guanidine thiocyanate, which produces a chemical reaction releasing cyanide gas when exposed to bleach (sodium hypochlorite).
  • CAP Statement on the Current Role of Serologic Testing for SARS-CoV-2. CAP President Patrick Godbey, MD, FCAP issued a statement regarding the Current Role of Serologic Testing for SARS-CoV-2, as there are still significant unknowns with respect to SARS-CoV-2 antibody testing, ranging from uncertainty regarding the accuracy of many commercially available assays to the clinical significance of positive results.
  • CAP Survey of Accredited Laboratories Confirms COVID-19 Testing Challenges. The CAP surveyed directors of clinical laboratories nationwide regarding the rate of COVID-19 testing, key barriers to expanding testing, and the impact on pathologists and other laboratory professionals. The survey confirms that while clinical laboratories are expanding testing, over 60% of laboratory directors report difficulties in obtaining critical supplies needed to conduct COVID-19 testing. Download our survey findings briefRe-watch our Town Hall with CAP-Accredited Laboratories.
  • On April 30, 2020, the Centers for Medicare and Medicaid Services (CMS) issued resources for CLIA-certified laboratories outlining testing requirements for SARS-CoV-2. They provide information on:
    • The types of SARS-CoV-2 testing and FDA authorization/notification
    • CLIA certifications under which each test can be performed
    • An explanation of requirements under each testing scenario
    • Information for Medicare beneficiaries on testing services and coverage
  • The CAP is providing guidance for CAP-Accredited Laboratories to ensure availability of reliable testing for rapid detection of the agent that causes COVID-19.
  • Implementing a SARS-CoV-2 Test in Your Laboratory. The CAP clarifies and simplifies the rules of compliance so that you can efficiently and safely introduce testing in your laboratory to serve your patients during this public health emergency.
  • Best Practices for Using Biologic Safety Cabinets While Testing for COVID-19. During this evolving landscape of testing for the SARS-CoV-2 virus, employ proper standards for using a biologic safety cabinet.

CAP US Inspections

Resuming Routine US Inspections

In June, the CAP began to slowly resume conducting routine inspections. The CAP is aware that the pandemic is ongoing and fluid. As inspections are planned the primary concern for all parties involved is health and safety and doing everything possible to reduce risk. To address this the CAP will help facilitate communications between the inspection teams and inspection sites to ensure that it is safe to begin planning the inspection.

The CAP is recommending a modified inspection process to adapt to the current climate in health care and to provide for increased safety measures. Learn more about our recommended pre-inspection document review step and our 2020 Modified Inspections Toolkit.

All inspections will be announced during this time and prioritized based on several factors. These factors include the phase of reopening achieved by the state in which the laboratory and inspectors are located, any COVID outbreaks or hot spot activity in the area the laboratory or inspector are located, and other restrictions that may impact the inspectors’ ability to travel for the inspection. The CAP does not recommend scheduling inspections in areas with current outbreaks or hot spot activity. The CAP asks the laboratory directors and accreditation contacts to communicate any changes in the local area as soon as possible. For inspectors who are located in areas with ongoing outbreaks or hot spot activity, we ask that you not plan to participate in any inspections until your local area situation has improved.

To further reduce risk during this time the CAP is recommending modifying the inspection when possible through a remote document review within the two weeks prior to the on-site inspection occurring. The CAP will not have inspectors in patient care areas during the on-site—aspects of this portion of the inspection should be conducted as interviews. Everyone should minimally be following the CDC guidelines, including those related to social distancing and wearing appropriate PPE. The CAP is also recommending summation conferences and interviews be conducted via phone or video conferencing when space is not available that allows for social distancing.

For Laboratories Whose Inspection is Past the Anniversary Date OR in the Inspection Window

If your laboratory inspection is late due to the COVID-19 pandemic, rest assured your accreditation continues. A letter from the CAP documenting that your laboratory is still accredited and outlining actions the laboratory is expected to take to maintain ongoing compliance should have been sent to the Director of the site. If your laboratory director has not received this letter, or needs a new copy, please contact us at LAPAssignments@cap.org.

When it comes to scheduling your inspection, you will be contacted by your assigned team leader or a member of the CAP assignments staff to confirm planned inspection dates, number of team members, and any other requirements that may be in place at your facility for the inspection team. We will work with your assigned inspection team to complete your inspection as soon as it is practical and possible to do so safely.

For Laboratories Who Have Not Reached the Inspection Window

We will work with your assigned inspection team to complete your inspection within your inspection window as much as is practical and possible to do so safely. Your inspection will be announced, and you will be contacted by your assigned team leader or a member of the CAP assignments staff to confirm planned inspection dates, number of team members, and any entry requirements that may be in place at your facility for the inspection team.

CAP Inspections Delayed Internationally

Internationally, the CAP has postponed most scheduled and requested laboratory inspections at this time. Some inspections using regional inspection teams may begin occurring in areas where this is possible and practical. During this time, impacted laboratories will remain CAP accredited. Additionally, to maintain quality and safety during this time, impacted laboratories should continue proficiency testing (PT) participation and follow all CAP requirements.

For CAP PT Customers

The CAP offers three SARS-CoV-2 PT programs (molecular, serology, and antigen) and one Quality Cross Check program in molecular. Learn more

New statement on Serologic Testing for SARS-CoV-2. View here

The CAP is committed to working with your laboratory to manage kit deliveries, stability concerns, and regulatory requirements, just to name a few. To date, the CAP has taken the following actions:

  • We are delaying some shipments.
    • We continue to monitor international restrictions and to hold shipments, when possible.
  • We are extending due dates, when possible.
    • The CAP will automatically extend due dates for international customers when shipments are released.

Shipping, Testing, and Due Date Information

For international customers
The CAP has resumed proficiency testing (PT) shipments on schedule. However, we anticipate some in-transit delays mostly related to carrier service limitations, flight restrictions, and greater customs scrutiny on PT shipments. Refer to My PT Shipping Calendar for a current, customized list of your laboratory’s shipments and updated due dates.

  • For access, click Access e-LAB Solutions Suite, then click My PT Shipping Calendar on the lower left-hand corner of the page.

When your laboratory receives a kit, perform testing immediately. Please continue to contact the CAP if you are receiving shipments in unsuitable conditions.

For all PT customers
If the due date for a program that your laboratory is enrolled in is approaching, please submit data at your earliest convenience by accessing your result form on cap.org via e-LAB Solutions Suite. If your laboratory is unable to complete testing, select one of the following exception codes on your result form to avoid penalty on your evaluation. You do not need to call the CAP to use either code.

  • Code 11 (Unable to analyze):
    Use code 11 to indicate your laboratory was or is closed due to the COVID-19 pandemic or was unable to analyze the specimens (eg, instrument not functioning, reagents not available).
  • Code 33 (Specimen unsatisfactory):
    Use code 33 to indicate your laboratory never received a kit, if a kit was delivered with unusable material (eg, specimens no longer stable), or if the CAP was unable to fulfill your replacement request.

Printed participant summaries and evaluations will continue to be mailed to laboratories, but they may be delayed.

For laboratories that may have limited staff or are temporarily closed, you will need to arrange to receive shipments that the CAP is unable to delay. 

Per the Centers for Medicare & Medicaid Services’ (CMS) Clinical Laboratory Improvement Amendments (CLIA) Laboratory Guidance During COVID-19 Public Health Emergency document, “in the event where a laboratory temporarily suspends performing a specific test due to staffing shortage, supply shortage, or reagent shortage:

  • The laboratory must document the timeframe during which the test is not being performed, and the reason therefore.
  • The laboratory must notify the inspecting agency and PT program within the timeframe of submitting PT results that it has ceased testing, and the reason therefore.
  • If the laboratory is still performing, or resumes such testing, and providing patient results, PT is still required and must be performed, as required by the CLIA regulations.” 

If your laboratory is currently unable to perform testing, hold the material and use it for alternative assessment when routine testing circumstances resume. If your laboratory is holding material for testing beyond the kit due date, use exception code 11 on your result form to indicate your laboratory was unable to analyze the specimens and document the reason in the Use of Other section. You do not need to call the CAP to use this code. 

For more information, please access the following:

COVID-19 Resources

  • COVID-19 fee-for-service autopsy list compiled by the CAP Autopsy Committee Review the list
  • COVID-19 Autopsy Guideline Statement from the CAP Autopsy Committee Read the Statement
  • A Remote sign-out of cases with Digital Pathology FAQs published. Read the FAQs
  • Subject matter experts from the Informatics Committee compile resources for COVID-19. Read more
  • The Cytopathology Committee offers some considerations for cytopathology services during COVID-19. Read the update
  • Transfusion, Apheresis and Cellular Therapy Committee provides information on concerns for the national blood supply. Read the update

Advocacy News and Legislative Alerts

Here is the latest news and/or action that the CAP has taken for its members on the legislative front:

  • CAP Demands Rationale from CDC on COVID-19 Testing Guidance
    The CAP applauds the AMA’s recent statement CDC changes to COVID-19 testing guidance and likewise urges the CDC and HHS to provide the scientific rationale when such guidance is issued now and in the future.
  • CAP Opposes HHS Lab Penalties and for COVID-19 Reporting Requirements
    The CAP strongly opposes the new penalties that the Department of Health and Human Services (HHS) will impose on laboratories who do not meet the COVID-19 data reporting requirements. Read also COVID-19 Laboratory Reporting FAQs.
  • FDA Relaxes Emergency Use Authorization Requirement for COVID-19 LDTs. In a rescission of previous guidance, the Food and Drug Administration (FDA) will no longer require an emergency use authorization (EUA) of laboratory-developed tests (LDTs) for patients, including those used to diagnose COVID-19, and changed the current enforcement discretion policy. Read more
  • HHS Shares Email Address to Request Swabs, Transport Media. The HHS announced it is directly managing allocation of swabs and media, including viral transport medium (VTM), based on state and territory testing plans that were submitted in response to the Coronavirus Aid, Relief, and Economic Security (CARES) Act requirements. Learn more
  • In an August 3 letter to Congress, the CAP urged top leaders in the House and Senate to consider its recommendations to support pathologists and frontline providers in any comprehensive strategy.
  • CAP leaders met with White House officials to discuss persistent testing supply shortages. Further, the CAP has urged Congress to take steps to shore up testing supplies and equipment. 
  • Read the results of our June, CAP-accredited laboratories survey on how the COVID-19 pandemic is impacting laboratories in the United States. These findings follow our April survey of accredited laboratories.
  • The CAP sends letter to the Department of Health and Human Services to obtain clarity on new guidance specifying clinical laboratory reporting to HHS of COVID-19 test results along with other clinical data elements.
  • For pathology practices in need of financial assistance, you should apply now for Small Business Administration (SBA) loans. On April 3, the CAP outlined and provided key links to resources in FAQs about the SBA loans. These loans are available on a first come, first serve basis and are open for application until June 30. Provide us with your feedback and additional questions about these financial programs by emailing the CAP at smallbusiness@cap.org.
  • Read more about our latest advocacy efforts, including securing a remote work waiver for pathologists and provisions in the $2 trillion stimulus bill. New FAQs summarize regulatory and payment issues affecting pathologists during the COVID-19 pandemic. Get the answers.
  • Read new FAQs summarizing regulatory and payment issues affecting pathologists during the COVID-19 pandemic. Get the answers

More resources:

CAP Survey of Laboratories Confirms COVID-19 Testing Challenges, Supply Shortages, and Excess Capacity

CAP Requests Additional Funding for Paycheck Protection Program

CAP Answers to Your Questions about Small Business Assistance During COVID-19

States Waiving Licensure Requirements/Renewals

New flexibilities from the CMS include in-place testing for home and community-based settings

CAP secures remote work waiver from CMS for pathologists

COVID-19 - Remote Sign-Out Guidance

Letter from Congress asking HHS to give pathologists the remote work flexibility advocated for by the CAP

CAP Calls on Health Officials to Give Labs, Pathologists Greater Flexibility for COVID-19 Pandemic

Letter to the US Department of Health and Human Services

Practice Resources for Pathologists

We have complied resources for you and your practice to help ease the burden you face during the COVID-19 pandemic. 

The CAP’s Coping with COVID-19 Impacts on the Pathologist Workforce
Tuesday, August 11, 2020, at 2:00 pm CDT

Register now for our virtual roundtable to hear real-world strategies to offset the impact of COVID-19 on your practice. You will learn:

  • The impact of COVID-19 on the pathologist workforce at a national level
  • Strategies being used by peers to address recruiting and staffing issues, pathologist pay and benefits, and mitigating loss of income

The CAP’s COVID-19 Financial Assistance Programs Roundtable
Tuesday, April 28, 2020, at 1:00 pm CDT

View this timely CAP member-led virtual roundtable to gain a better understanding of key financial assistance programs made available by Congress and learn about:

  • Financial assistance programs available to pathologists
  • Tools developed by the CAP to assist you with applications
  • Downstream implications to consider when obtaining assistance

Watch now

We will continue to add resources as they become available. Any questions or feedback is welcome: advocacyupdate@cap.org

Financial Assistance Programs

For pathology practices, we recognize many pathologists have experienced a sudden loss in revenue due to a drop in anatomic pathology services and other difficulties. The Coronavirus Aid, Relief, and Economic Security (CARES) Act established several new programs and funding sources to help address these shortfalls, which are applicable to pathologists and their practices/laboratories. The Paycheck Protection Program and Health Care Enhancement Act provided additional funds.

  • Jonathan Myles, MD, FCAP, chair of the CAP’s Council on Government and Professional Affairs, reviews assistance programs available to pathologists in this CAPcast.
  • Links to resources for pathologists looking to obtain financial assistance can be found in the CAP’s FAQs about the SBA loans. The FAQs include information to let you know what is available from the CARES Act and other federal government programs.
  • Provide us with your feedback and additional questions about these financial programs at smallbusiness@cap.org.

CAP members address financial assistance during COVID-19

  • Matthew Foster, MD, FCAP
  • Theresa Emory, MD, FCAP

Medicare Accelerated and Advance Payment Program

UPDATE: On April 26, 2020, the Centers for Medicare & Medicaid Services (CMS) announced that it is suspending its advance payment program effective immediately. According to CMS, this decision was reached in part because of the $175 billion recently appropriate for health care provider relief payments. For more on the relief payments, see the “Direct Provider Relief” section below. For more on this CMS decision, read the agency press release online here.

The CARES Act and the CMS expanded the accelerated and advance payment program for Medicare participating physicians and other providers to ensure they have resources needed to combat COVID-19. The advance payments are not a grant, and recoupment begins 120 days after initial payment for all providers. Physicians billing under Part B will have 210 days from the date of the accelerated or advance payment was made to repay the balance. Interest attaches to any outstanding balance after this date.

Paycheck Protection Program

On April 24, 2020, President Trump signed into law legislation that provides additional funding for the Paycheck Protection Program (PPP). This program, created as part of the CARES Act, provides small businesses with a loan for the purposes of retaining employees. Physician practices with 500 or fewer employees, sole proprietors, independent contractors, and self-employed persons are eligible to apply. You can apply through any existing SBA 7(a) lender or through any federally insured depository institution, federally insured credit union, and Farm Credit System institution that is participating. The loan will be fully forgiven if the funds are used for payroll costs, interest on mortgages, rent, and utilities (at least 75% of the forgiven amount must have been used for payroll).

  • To help expedite the PPP application process, the CAP has developed an application roadmap to provide general guidance and a PPP worksheet for estimating eligible funding amounts when preparing to apply for a loan under the Paycheck Protection Program.

Loan Forgiveness: Paycheck Protection Program

If your practice received a Paycheck Protection Program (PPP) loan you may now apply for forgiveness of up to 100% of the loan amount. The Loan Forgiveness Application must be completed by October 31, 2020 and list how the funds were utilized. If they were utilized in compliance with the PPP requirements practices may be able to obtain 100% forgiveness. Once completed, this form should be submitted to your lender for consideration.

Emergency Economic Injury Disaster Loans (EIDL) and Loan Advance

A new economic injury emergency grant program provides up to $10,000 to small businesses and private nonprofits harmed by COVID-19 within three days of applying for an EIDL loan. Funds will be made available following a successful application. This loan advance will not have to be repaid.

The Small Business Administration (SBA) EIDL program provides loans of up to $2 million to small businesses with less than 500 employees (including sole proprietorships, independent contractors and self-employed persons) that are experiencing temporary loss of revenue as a result of COVID-19. 

More information is available on the SBA website.

Other SBA Loans and Debt Relief

The CARES Act also made available $17 billion is available for immediate relief to small businesses with non-disaster SBA loans, in particular 7(a), 504, and microloans. Under it, SBA will cover all loan payments on these SBA loans, including principal, interest, and fees, for six months.

Apply now for SBA loans. Small business guidance and loan resources are also available on the SBA website.

Direct Provider Relief

Congress has appropriated over $100 billion for a Provider Relief Fund to reimburse providers for lost revenues and increased expenses due to the coronavirus pandemic. Starting April 10, 2020, the Department of Health and Human Services (HHS) initiated delivery of $30 billion in relief funding to providers in proportion to their Medicare fee-for-service payments in 2019. Providers were not required to engage in any activity or apply for these funds, which do not have to be repaid. The funds were sent directly to providers in the same fashion other Medicare payments are normally sent to your practice. However, in order to retain these funds, practices are required to sign an attestation form and agree to certain terms and conditions. Not returning the payment within 45 days of receipt of payment will be viewed as acceptance of the terms and conditions.

Starting April 24, 2020, an additional $20 billion was made available to reconcile the initial payment (if any) so that the provider ultimately receives a proportion of a provider’s 2018 patient revenue. Only Medicare providers who have already received a payment from the Provider Relief Fund will be eligible to apply for this additional wave of funds.

The CAP has developed a FAQ guide for members with questions related to the Provider Relief Fund payment, available online here. Another short guide on the process of requesting or confirming additional funds is available online here. Visit hhs.gov/providerrelief for additional information.

Resources for Remote Working

CLIA regulations mandate that pathologists must perform diagnostic tests in CLIA-licensed facilities. But the CMS stated during this public health emergency, it will exercise enforcement discretion to ensure pathologists may review pathology slides remotely using these guidelines. The FDA released additional guidance regarding digital pathology devices used during the public health emergency.

CAP members address remote working during COVID-19

  • Anil Parwani, MD, PhD, MBA, FCAP
  • Liron Pantanowitz, MD, FCAP

Regulatory Relief During the COVID-19 Crisis

Members and staff from the CAP’s Council on Government and Professional Affairs have developed the following FAQs to help summarize regulatory and payment issues affecting pathologists during the COVID-19 pandemic.

Other Guidance

  • CPT Guidance: The CMS issued guidance to ensure coverage of COVID-19 diagnostic testing, including antibody testing, at no cost for those with private health insurance. Additionally, the AMA approved and revised COVID-19 CPT codes with critical input from the Pathology Coding Caucus, which is an advisory group to AMA CPT chaired by Ronald McLawhon, MD, FCAP. The AMA new COVID-19 CPT codes provide laboratories a more specific reporting mechanism for antibody tests for severe acute respiratory syndrome coronavirus 2.

Topic Center

Our thought leadership from a wide array of councils and committees have responded to the COVID-19 pandemic. Visit our topic center for essential information and guidance.

CAP Meetings, Events, and Education

CAP20 is virtual – learn more and register!

Previous Webinars

  • Coping with COVID-19 Impacts on the Pathologist Workforce
    Join our virtual roundtable to hear real-world strategies to offset the impact of COVID-19 on your practice.
    Access the webinar
  • Post COVID-COVID – Will We Be Better Prepared for Round Two?
    Evaluate best practices of recovery in the immediate post-COVID crisis and propose a preparedness plan to sustain a resurgence of the pandemic.
    Access the webinar
  • You’ve Been Asked to Implement SARS-CoV-2 Antibody Testing: What You Need to Know 
    Learn about the CAP’s statement on the current role of serologic testing as well as the difference between the clinical impact of an antibody test result versus a molecular test result. 
    Access the webinar
  • Navigating Implementation of SARS-CoV-2 Testing in Your Laboratory
    This webinar covers what is required for verification and validation when bringing up a new test plus ongoing requirements for personnel and quality monitoring to keep the test running.
    Access the webinar

New Learning Opportunities for our Members

Postponed Learning Courses

Information on Events and Committee Meetings

  • If you are registered for an event, we will contact you with any changes. 
  • For CAP committee meetings, please contact your committee staff person for updates as to whether your meeting will be held virtually, postponed, or cancelled.
  • CAP20 is virtual – learn more and register!
  • For the Pathologists Leadership Summit, the summit has been cancelled. Registrants, please visit Pathologists Leadership Summit for details and actions to take for cancelling hotel and airline reservations.

CAP in the News and on Social Media

CAP Officers/Members Address COVID-19 Issues

  • Jonathan Lai, MD
  • Justin Snow, MD, FCAP
  • Mary Fowkes, MD, PhD, FCAP

Twitter Chat Wrap-ups

How Pathologists Can Navigate COVID-19-Related Practice Management Challenges.

Recap of the discussion about the resources available to pathologists as we navigate the practice management-related challenges resulting from the impact of COVID-19. Hosted by Brian H. Le, MD, FCAP.

Ramping Up Your Lab’s COVID-19 Testing Capabilities: Best Practices & Lessons Learned Diagnosing 

Recap of the March 31, 2020 Twitter chat on challenges pathologists are facing, and overcoming, as more laboratories implement COVID-19 diagnostic testing. Hosted by ​CAP member Ziad El-Zaatari, MD. 

Diagnosing COVID-19: What Pathologists Need to Know Now

Recap of the March 10, 2020 Twitter chat focusing on what pathologists need to know about their role in diagnosing and treating patients suspected to have COVID-19. Hosted by ​CAP member Ziad El-Zaatari, MD.

CAPcasts

Listen to COVID-19 experiences, guidance, and advice.

Using Proficiency Testing to Ensure Accurate SARS-CoV-2 Testing
Bobbi Pritt, MD, FCAP, who chairs the CAP’s Microbiology Committee, discusses what pathologists and laboratories need to know about SARS-CoV-2. Dr. Pritt and committee members were instrumental in designing the CAP’s proficiency testing program for SARS-CoV-2, the novel coronavirus.

Using Proficiency Testing to Ensure Accurate SARS-CoV-2 Testing

How the Federal Small Business Loan Program Can Help Pathology Practices
Jonathan Myles, MD, FCAP, who chairs the CAP’s Council on Government and Professional Affairs, explains how the federal small business loan program can help pathologists keep their practices solvent until the pandemic and national emergency are over.

How the Federal Small Business Loan Program Can Help Pathology Practices

Diagnosing COVID-19: How OHSU Pathologists Launched Testing in 15 Days
In this CAPcast interview, Richard Scanlan, MD, FCAP discusses his experiences bringing COVID-19 testing online at his institution, including some lessons learned. Dr. Scanlan is the medical director of the Oregon Health and Sciences University Hospital laboratory in Portland, Oregon.

Diagnosing COVID-19: How OHSU Pathologists Launched Testing in 15 Days

CAPcast: Diagnosing COVID-19: Advice from UW Pathologists on Ramping Up Testing Capacity
Seattle experienced the COVID-19 pandemic’s first wave in the United States. UW Medicine’s Geoffrey Baird, MD, PhD, acting chair of Laboratory Medicine was at the forefront, confronting significant challenges related to diagnosing patients with this virus. In this CAPcast, Dr. Baird discusses lessons learned from testing and personnel challenges when ramping up testing capacity. In addition, Suzanne Dintzis, MD, PhD, FCAP, Associate Professor of Pathology at UW School of Medicine and current president of the Washington State Society of Pathologists, weighs in on UW’s current autopsy protocols.

Diagnosing COVID-19: Advice from UW Pathologists on Ramping Up Testing Capacity

CAP in the Media

The CAP has been working proactively to share our members’ expertise.

(please note some links may require subscriptions or may outdate due to host site changes)

  • Open all Toggle
  • Close all Toggle

The Best Home Health Tests for Everything from Covid-19 to UTIs
First For Women - September 16, 2020
CAP President-Elect Emily Volk, MD, MBA, FCAP, on behalf of the CAP, speaks about the importance of properly administering at-home tests for COVID-19.

AMA COVID-19 daily video update: What doctors wish patients knew about wearing masks
American Medical Association - September 16, 2020
Nicole Riddle, MD, FCAP, talks with other health care experts in this AMA video on the importance of wearing masks to prevent the spread of COVID-19.

Despite Greater Demand From Nursing Homes, Dx Firms Confident About COVID-19 Rapid Testing Capacity
360Dx - September 14, 2020
CAP President-Elect Emily Volk, MD, MBA, FCAP, speaks on behalf of the CAP on the difficulties facing increased COVID-19 testing including supply shortages.

Could saliva and rapid antigen tests be coronavirus game-changers in time for family gatherings this holiday season?
Cleveland.com - September 14, 2020
Daniel Rhoads, MD, FCAP, discusses the types of COVID-19 tests available including their proper uses and potential drawbacks.

AdventHealth expands COVID-19 antigen testing for staff
Orlando Sentinel - September 12, 2020
CAP President Patrick Godbey, MD, FCAP, on behalf of the CAP, explains the pros and cons of antigen testing for COVID-19: “The problem with many antigen tests is sensitivity. In other words, if I have COVID-19, how likely is it that this test is going to say I have COVID-19 and that varies tremendously.”

Faster, cheaper virus tests needed heading into Fall
The Atlanta Journal-Constitution - September 12, 2020
CAP President Patrick Godbey, MD, FCAP, on behalf of the CAP, discusses the need for more COVID-19 testing supplies and increased capabilities for local laboratories. The CAP's laboratory surveys on COVID-19 testing are also referenced.

Broad COVID-19 testing under microscope
StarTribune.com - September 12, 2020
Bobbi Pritt, MD, FCAP, explains high-cycle positives for COVID-19 tests and discusses the CAP's proficiency testing for SARS-CoV-2.

To Stop Coronavirus’ Spread, We’ll Need New Testing Technology
Discover Magazine - September 11, 2020
Benjamin Pinsky, MD, PhD, FCAP, references a recent study in which his team compared different types of COVID-19 tests.

UT researchers help develop more accurate, lower cost COVID-19 antibody test
FOX 7 Austin - September 11, 2020
Eric Salazar, MD, PhD, FCAP, authored a study that used an enzyme-linked immunosorbent assays COVID-19 test to evaluate 2,814 blood samples used in an ongoing study of convalescent plasma therapy.

In the absence of uniform instructions, many Bay Area schools and districts are left to create coronavirus testing programs on their own, resulting in plans that vary greatly in approach, cost and testing frequency.
San Francisco Chronicle - September 10, 2020
Christina Kong, MD, FCAP, discusses the effectiveness of pooled testing in monitoring community spread of COVID-19.

Do you need a COVID-19 test if you plan to travel? Do you still need to quarantine? What to know about the confusing rules.
USA Today - September 4, 2020
The article references an August CAP survey of 1,000 US consumers on COVID-19, which showed 91% of respondents believed getting easy to understand test results was "very important."

The Rapidly Changing COVID-19 Testing Landscape: Where Are We? Where Are We Going? Watch the replay of the CAP Media Briefing
College of American Pathologists - September 3, 2020
A recording of the CAP's livestreamed COVID-19 media briefing from Tuesday, September 1. Panelists include Valerie Fitzhugh, MD, FCAP; Patrick Godbey, MD, FCAP; Bobbi Pritt, MD, FCAP; and Emily Volk, MD, MBA, FCAP.

Pathologists Explore COVID-19 Testing Challenges, Breakthroughs
Medpage Today - September 2, 2020
Coverage of the CAP's COVID-19 virtual media briefing featuring Valerie Fitzhugh, MD, FCAP; Patrick Godbey, MD, FCAP; Bobbi Pritt, MD, FCAP; and Emily Volk, MD, MBA, FCAP.

Would Abbott's antigen test solve COVID-19 testing problems? Stakeholders emphasize caution
Modern Healthcare - September 1, 2020
CAP President-Elect Emily Volk, MD, MBA, FCAP, on behalf of the CAP, discusses the potential impact of a new antigen test for SARS-CoV-2 that received emergency use authorization, as well as concerns regarding the test's expectations. Alex Greninger, MD, PhD, FCAP, also comments.

Metro health experts say new CDC report on COVID-19 deaths is misleading
FOX4 - August 31, 2020
Diane Peterson, MD, FCAP, explains how medical examiners complete death certificates--including the definition of underlying conditions--which are then used to track COVID-19 deaths.

Companies Rush to Shore Up Covid-19 Testing Ahead of Flu Season
The Wall Street Journal - August 30, 2020
CAP President-Elect Emily Volk, MD, MBA, FCAP, on behalf of the CAP, discusses the difficulties posed by the convergence of flu season and the ongoing pandemic.

Cuts in Medicare payments are hurting physicians and access to healthcare | PennLive letters
PennLive.com - August 29, 2020
Anthony Simonetti, MD, MBA, FCAP, member of the CAP's Engaged Leaders Network, writes on the important role of pathology during the pandemic, and warns against proposed January 2021 Medicare payment cuts.

3 Michigan health systems won't follow CDC's new coronavirus test guidelines — yet
Detroit Free Press - August 28, 2020
Peter Millward, MD, FCAP, comments on COVID-19 testing protocols at Beaumont Health, saying decisions about whether asymptomatic people who've been exposed to COVID-19 should be tested "has always been left up to the clinician/doctor’s discretion.”

Not all coronavirus tests are the same: What to know about the different types
Detroit Free Press - August 28, 2020
Richard Zarbo, MD, DMD, FCAP, guides readers through the different types of tests for COVID-19: "If you're looking for a diagnostic test to diagnose whether you have COVID or not, the best test, the gold standard, is a PCR-based test out of a hospital-based laboratory or a reference laboratory."

Symptomatic and Asymptomatic Viral Shedding in Pediatric Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Under the Surface
The JAMA Network - August 28, 2020
Meghan Delaney, DO, MPH, FCAP, coauthored this editorial on the effects of COVID-19 on children and the likelihood that many are unknowingly spreading the virus.

VERIFY: No, coronavirus death counts aren't being inflated
Krem.com - August 27, 2020
Sally Aiken, MD, FCAP, explains the process for counting COVID-19 deaths and says the data do not show that deaths are being intentionally or unintentionally inflated.

Want to get a COVID-19 antibody test? Consider donating blood
Kgw.com - August 25, 2020
Donna Hansel, MD, PhD, FCAP, discusses COVID-19 antibody tests: "We still have a long way to go to understand what those antibodies mean, if it offers any sort of protections, and also how long hose antibodies last."

COVID-19 Autopsies Reveal Ravages of 'Terrible, Terrible' Disease
Medscape - August 21, 2020
Alex Williamson, MD, FCAP, member of the CAP's Autopsy Committee, speaks on behalf of the organization when discussing the details pathologists have learned from autopsies on COVID-19 patients. Bennet Omalu, MD, MBA, MPH, FCAP, and Amy Rapkiewicz, MD, FCAP, also comment.

What Maryland’s statewide COVID-19 antibody study entails and hopes to reveal
WTOP.com - August 21, 2020
Moira Larsen, MD, MBA, FCAP, is working on a statewide study in Maryland that is attempting to learn more about the spread of COVID-19 through large-scale antibody testing.

Fishing boat outbreak suggests antibodies protect against COVID-19 reinfection
LiveScience - August 21, 2020
Alex Greninger, MD, PhD, FCAP, studied an outbreak of COVID-19 on a fishing boat, which provides some of the best evidence to date that antibodies can protect people from the virus.

Mother transmitted COVID-19 to baby during pregnancy, UTSW physicians report
UT Southwestern Medical Center - August 20, 2020
Dinesh Rakheja, MD, FCAP, explains his diagnosis and further analysis of an infant who contracted COVID-19 from its mother.

ARUP/U of U Health Study Finds Self-Collected Saliva and Deep Nasal Swabs Are Equally Effective for the Diagnosis of COVID-19
University of Utah Health Care - August 20, 2020
Julio Delgado, MD, FCAP, chief medical officer at ARUP, completed the largest study of COVID-19 test collection methods, which found self-collected saliva and deep nasal swabs collected by healthcare providers are equally effective for detecting SARS-CoV-2.

3 More New Hampshire Residents Die During Coronavirus Pandemic
Yahoo news - August 19, 2020
Isabella Martin, MD, FCAP, is conducting research on the presence of SARS-CoV-2 in wastewater to help understand the virus's spread in certain regions.

Why Pooled Testing for the Coronavirus Isn't Working
The New York Times - August 18, 2020
Christina Kong, MD, FCAP, comments on the effectiveness of COVID-19 pooled testing to help with contact tracing for tracking outbreaks in social groups like schools.

Carroll Hospital enters partnership to study how many people have gotten COVID-19, and where
The Baltimore Sun - August 18, 2020
Christopher Grove, MD, FCAP, chief of pathology at Carroll Hospital, will work with 13 other hospital laboratories in Maryland on a COVID-19 antibody study.

COVID-19 Saliva Test: 5 Fast Facts You Need to Know
Heavy.com - August 15, 2020
Chen Liu, MD, PhD, FCAP, comments on increased testing capacity from a new saliva-based laboratory diagnostic test.

How will COVID-19 affect the coming flu season? Scientists struggle for clues
Science - August 14, 2020
Benjamin Pinsky, MD, PhD, FCAP, co-authored a study on interactions between seasonal respiratory viruses and SARS-CoV-2.

New study questions effectiveness of neck fleece masks
Kens5.com - August 10, 2020
CAP President-Elect Emily Volk, MD, MBA, FCAP, explains how masks help stop the spread of COVID-19 and comments on a recent study on the effectiveness of different types of face coverings.

‘It’s Like Having No Testing’: Coronavirus Test Results Are Still Delayed
The New York Times - August 5, 2020
CAP President Patrick Godbey, MD, FCAP, is interviewed on COVID-19 testing issues. “We literally ration tests,” said Dr. Godbey on supply shortages that he's experienced at his laboratories.

States band together to get rapid COVID-19 tests – so why isn’t Georgia one of them?
Wsbtv.com - August 5, 2020
CAP President-Elect Emily Volk, MD, MBA, FCAP, comments on the supply shortage for COVID-19 tests in this story covering a new interstate initiative to procure more rapid COVID-19 tests.

I'm an Infectious Disease Doctor and Here's When This Will All Be Over
Eat This - August 5, 2020
Sheldon Campbell, MD, PhD, FCAP, describes the long-term presence of COVID-19 and gives his opinion on best-case scenarios saying, "It's going to tail off, not end abruptly. I think COVID-19 will be with us indefinitely."

Covid-19 testing delays create a public health nightmare as schools and workplaces try to reopen
CNBC - August 2, 2020
The article cites the CAP's COVID-19 laboratory survey mentioning testing supply shortages. Karen Kaul, MD, PhD, FCAP, also comments on the difficulty of finding testing supplies.

New Research Defines Intrauterine Placental Transmission of COVID-19 From Pregnant Women to the Fetus
Market Screener - July 30, 2020
David Schwartz, MD, FCAP, led a study to examine whether vertical transmission occurs and if it develops in the uterus prior to delivery in a new research article published in the Archives of Pathology & Laboratory Medicine.

‘Trib Talk’: A Utah ER doctor and a medical examiner discuss the fight against COVID-19
The Salt Lake Tribune - August 3, 2020
Erik Christensen, MD, FCAP, medical examiner for Utah, discusses COVID-19 and its impact in the state.

‘I want to know what happened to him’: Family seeks answers for Oregon's youngest COVID-19 fatality
OregonLive - July 31, 2020
Desiree Marshall, MD, FCAP, reviewed an autopsy summary and describes the likely cause of death for Oregon's youngest COVID-19 patient.

FDA opens door to rapid, at-home screening for COVID-19
USA Today - July 29, 2020
CAP President-Elect Emily Volk, MD, MBA, FCAP, comments on behalf of the CAP on the accuracy and validity of rapid testing.

How to Test More People for Coronavirus Without Actually Needing More Tests
The New York Times - July 27, 2020
Steven Hinrichs, MD, FCAP, discusses how his team at the University of Nebraska Medical Center has used pooled COVID-19 testing for public health surveillance.

Stanford Health Care can begin pooled testing for COVID-19
Stanford Medicine - July 27, 2020
Christina Kong, MD, FCAP, discusses the best uses for pooled testing for COVID-19.

COVID-19 testing capacity and supplies are strained. Some labs are turning to pooling tests to meet the demand.
USA Today - July 25, 2020
Emily Volk, MD, MBA, FCAP, and CAP president-elect, discusses pool testing and whether that can help ease the strain on US laboratories.

Self-Swab COVID-19 Home Testing Found Comparable
Medscape - July 22, 2020
Karen Kaul, MD, PhD, FCAP, comments on a new study on the effectiveness of at-home testing for COVID-19, saying, "Of note, the vast majority of participants in this study were health care workers themselves, raising the question as to whether they may do a better job in collecting a sample, compared to the general public."

Manchester Outbreak and COVID-19 Scams
WDEV Radio - July 22, 2020
Christina Wojewoda, MD, FCAP, vice chair of the CAP Microbiology Committee, discusses how a rapid antigen COVID-19 test works and what distinguishes it from PCR testing.

OU Medicine professors discuss COVID-19 testing, supply shortage in livestream interview
OU Daily - July 21, 2020
Cindy McCloskey, MD, FCAP, and Michael Talbert, MD, FCAP, from OU Medicine hosted a livestream to discuss issues surrounding COVID-19 testing.

Big Data and Collaboration Seek to Fight Covid-19
The Scientist Magazine - July 21, 2020
Stephen Hewitt, MD, PhD, FCAP, is currently aggregating and digitizing human tissue samples from deceased COVID-19 patients across the country as part of the National COVID Cohort Collaborative.

Months into pandemic, U.S. still can't get speedy testing right
Houston Chronicle - July 22, 2020
William Morice, MD, PhD, FCAP, discusses issues facing COVID-19 testing in the US, including improvements on timely turnaround and supply acquisition.

What Accounts For High Coronavirus Positivity Rates Among Florida Kids?
National Public Radio - July 17, 2020
Meghan Delaney, DO, MPH, FCAP, explains the high rates of children testing positive for COVID-19, particularly in Florida.

Uncounted millions had COVID-19 symptoms, but no positive test
USA Today - July 17, 2020
Donna Hansel, MD, PhD, FCAP, stresses the importance of accurate testing for COVID-19.

How Does COVID-19 Affect Your Body In The Long Term?
Player FM - July 16, 2020
Mary Fowkes, MD, PhD, FCAP, discusses the long term effects of COVID-19 on patients.

New Research Led by CAP Members Shows a 40% Pathology Workforce Undercount in Nationally Published Reports
Yahoo! Finance - July 16, 2020
Members of the CAP found a massive undercount of pathologists in a database of working US physicians that the Association of American Medical Colleges (AAMC) maintains and is referenced in recent published works on the pathology workforce. CAP Member authors include: Stanley J. Robboy, MD, FCAP; Jason Y. Park, MD, PhD, FCAP; James M. Crawford, MD, PhD, FCAP; Rebecca L. Johnson, MD, FCAP; Michael B. Cohen, MD, FCAP, Donald S. Karcher, MD, FCAP; Robert D. Hoffman II, MD, FCAP; and W. Stephen Black-Schaffer, MD, FCAP.
Read the study, "Reevaluation of the US Pathologist Workforce Size," in JAMA. 

Everything to Know About COVID-19 Antibody Testing
Allure Magazine - July 15, 2020
Amy Karger, MD, PhD, FCAP, chair of the CAP Point of Care Testing Committee, explains how antibody testing works and what the results can tell individuals and health experts about COVID-19.

Profile of a killer — Unraveling the deadly new coronavirus: ‘There’s light at the end of tunnel, but it’s a very, very long tunnel’
Chicago Tribune - July 15, 2020
Desiree Marshall, MD, FCAP, discusses the importance of autopsies in learning more about COVID-19 and its spread.

3M, MIT team up to develop quicker, cheaper COVID-19 test
StarTribune.com - July 14, 2020
CAP President-Elect Emily Volk, MD, MBA, FCAP, provides background on antigen tests.

Collection method, sample timing can impact COVID-19 test results
WRAL.com - July 13, 2020
George Clarke, MD, FCAP, explains how the collection process and patient exposure timeline can affect results of a COVID-19 test.

Covid-19 Coronvairus May Be Transmitted Via The Womb During Pregnancy
Forbes - July 13, 2020
Dinesh Rakheja, MD, FCAP, coauthored a case report that suggests a pregnant woman could potentially transmit SARS-CoV2 to the fetus through the womb.

Efforts to expand Massachusetts coronavirus testing hit snags
Boston Herald - July 12, 2020
Rebecca Osgood, MD, FCAP, describes several issues affecting the supply chain for COVID-19 testing.

Fact check: Though nasal test for COVID-19 swabs deep into the nose, nothing is implanted
USA Today - July 11, 2020
Micah Bhatti, MD, PhD, FCAP, explains why nasal swabs are used for COVID-19 testing in an article debunking recent internet conspiracy theories that speculate nasal swabs may be used to place implants in unsuspecting patients.

Pathologist found blood clots in 'almost every organ' during autopsies on Covid-19 patients
CNN - July 10, 2020
Amy Rapkiewicz, MD, FCAP, is interviewed on CNN's OutFront about autopsy findings that show extensive blood clotting in COVID-19 patients.

Labs plead with Pence for help with coronavirus test supplies
LabPulse.com - July 9, 2020
The CAP joins other laboratory organizations to request the federal government and Vice President Mike Pence to address persistent supply problems that are hampering molecular and serology testing for COVID-19.

How Accurate Are COVID-19 Diagnostic and Antibody Tests?
Healthline - July 8, 2020
President-Elect Emily Volk, MD, MBA, FCAP, and Christina Wojewoda, MD, FCAP, vice chair of the CAP Microbiology Committee, speak on behalf of the CAP on how to conduct different types of COVID-19 tests including the advantages and accuracy of each.

COVID-19 can’t pass the smell test
KABC - July 8, 2020
CAP President-Elect Emily Volk, MD, MBA, FCAP, comments on studies showing that some COVID-19 patients lose their sense of smell, saying viruses can often inflame the olfactory nerves.

Pathologist shares findings from autopsies of COVID-19 patients
MSNBC - July 8, 2020
Mary Elizabeth Fowkes, MD, PhD, FCAP, CAP Governor, discusses what pathologists have learned from autopsies on COVID-19 patients.

As coronavirus surges elsewhere, Nebraska labs report supply shortages, long wait times
Omaha.com - July 8, 2020
Deborah Perry, MD, FCAP, comments on COVID-19 testing supply shortages, especially reagents, at her Nebraska hospital laboratory.

Digital pathology to diagnose patients debuts in San Diego
San Diego Community News Group - July 5, 2020
Julie Steele, MD, FCAP, comments on the enhanced use of digital pathology at Scripps MD Anderson Cancer Center.

Samuel K. Caughron: Stop Medicare cuts to pathologists during pandemic
The Topeka Capital-Journal - July 4, 2020
Samuel K. Caughron, MD, FCAP, recounts the essential role of pathologists during the COVID-19 pandemic and warns against scheduled payment cuts to non-evaluation and management services in 2021.

Congress needs to protect physicians from Medicare cuts
The Hill - July 2, 2020
CAP President Patrick Godbey, MD, FCAP, authored this piece that covers the essential role of pathologists and other health professionals during the COVID-19 pandemic and how the federal government has helped support them through telemedicine and Paycheck Protection Program policies. However, the planned January 2021 payment reductions to all non-evaluation and management services is still of serious concern.

With spike in coronavirus infections, demand for COVID-19 testing surges in San Antonio
San Antonio Express-News - June 30, 2020
CAP President-Elect Emily Volk, MD, MBA, FCAP, co-chairs a COVID-19 Community Response Coalition for the San Antonio Area, which plans to survey local testing providers, laboratories, and employers every two weeks to gauge demand for testing.
Note: This article is only available to San Antonio Express-News subscribers.

CAP survey: Labs are high on coronavirus test capacity, but still short of supplies
LabPulse.com - July 1, 2020
CAP President Patrick Godbey, MD, FCAP, discusses the results of a newly released CAP survey of laboratories in the US.

Autopsies are more important than ever. Here’s what they can tell us.
Popular Science - July 1, 2020
Mary Fowkes, MD, PhD, FCAP, explains how pathologists conduct autopsies and what can be learned from them.
Dr. Fowkes also discussed autopsies in The Washington Post. 

Everyday Heroes: Hospital Laboratory Works Behind the Scenes
The Brunswick News - June 30, 2020
CAP President Patrick Godbey, MD, FCAP, discusses the essential role of medical laboratories during the COVID-19 pandemic: "We’re involved in the care of almost every hospital patient.”

Medical Laboratory Test Data and Clinical Lab 2.0 are Powering Dashboards That Help Providers Mitigate COVID-19 and Improve Population Health
Dark Daily - June 24, 2020
Jordan Olson, MD, FCAP, discusses the use of informatics dashboards in tracking COVID-19 testing data at Geisinger Health System.
This article is further pickup from an April article in 360Dx.

Digitizing And Automating Unsung Heroics: The Case Of Pathology
Forbes - June 23, 2020
Alexander Baras, MD, PhD, FCAP, director of informatics for the department of pathology and the director of precision medicine informatics at Johns Hopkins, discusses the details of digital pathology practice and resulting data. The CAP is also mentioned in regard to its lack of official approval on using AI for image analysis-based diagnosis.

I’m a COVID-19 lab director. This is why the integrity of my testing depends on investment in people
Fast Company - June 18, 2020
Li Jin, MD, PhD, FCAP, authored this article explaining the complexities of COVID-19 testing, the need for laboratory funding, and requirements for highly skilled laboratory professionals.

Galveston Co. provides free antibody tests after COVID-19 spike
ABC13.com - June 17, 2020
Michael Laposata, MD, PhD, FCAP, discusses the effectiveness of COVID-19 antibody tests and how he helped select what he sees as the best option for his hospital's patient community.

Harvey Fineberg Reviews the US Pandemic Response
Medscape - June 17, 2020
George Lundberg, MD, FCAP, interviews Harvey Fineberg, MD, PhD, of Harvard's Institute of Medicine on the US response to the COVID-19 pandemic.

Minnesota mass gathering participants eligible for COVID-19 testing
Mayo Clinic News Network - June 16, 2020
Bobbi Pritt, MD, FCAP, highlights the importance of proper follow up and precautions following a COVID-19 test: "Whether your results are positive or negative, it's important that you know so you can take the right steps in stopping the spread of the virus."

What Zebra Mussels Can Tell Us About Errors In Coronavirus Tests
National Public Radio - June 15, 2020
The CAP's COVID-19 proficiency testing is mentioned and Bobbi Pritt, MD, FCAP, chair of the CAP Microbiology Committee, comments on new research on how PCR testing and its use on studying mussels could help reduce false positive tests for COVID-19. Listen to the full radio interview. 

In-house antibody testing now available through University of Iowa Health Care
KWQC-TV6 News - June 15, 2020
Matthew Krasowski, MD, PhD, FCAP, comments on the antibody testing for COVID-19 available at University of Iowa Health Care, but says, "However, it’s important to note that we don’t yet know if antibodies will provide protective immunity against COVID-19.”

Antibody testing for COVID-19 not as helpful as hoped
Pittsburgh Post-Gazette - June 13, 2020
Kymberly Gyure, MD, FCAP, says the current use of antibody testing for COVID-19 is limited, mostly for small epidemiological studies or to use as a screen for plasma donors.

Science in Action: The medical complexity of COVID-19
BBC - June 4, 2020
On the BBC podcast "Science in Action," Mary Fowkes, MD, PhD, FCAP, and member of the CAP Board of Governors, discusses the occurrence of strokes in COVID-19 patients as well as the disruption of the immune system.

Cancer Researchers Have a Head Start in Fight Against COVID-19
Roswellpark - June 3, 2020
Joanne Becker, MD, FCAP, has been leading convalescent plasma treatment for COVID-19 at Roswell Park Comprehensive Cancer Center.

WVU producing swabs for virus testing
Hampshire Review - June 3, 2020
Peter Perrotta, MD, FCAP, comments on the shortages of critical testing supplies and the production of swabs at West Virginia University.

Video and Transcript--Testing, Testing, and More Testing: Newswise Live COVID-19 Expert Panel
Newswise - May 29, 2020
The CAP hosted a virtual news conference on COVID-19 testing featuring Patrick Godbey, MD, FCAP; Bobbi S. Pritt, MD, FCAP; Raouf Nahkleh, MD, FCAP; and Emily Volk, MD, FCAP. The panel discusses the status of testing capacity and the types of tests available including antigen testing.

How many people have coronavirus? Sometimes, it's just a guess
CNN.com - May 26, 2020
Michael Misialek, MD, FCAP, discusses the use of a tracheal aspirate test for making a difficult COVID-19 diagnosis as well as the various factors that can affect testing accuracy.

Here's How to Use Hand Sanitizer the Right Way
InStyle - May 26, 2020
Christina Wojewoda, MD, FCAP, on behalf of the CAP, explains the effectiveness of hand sanitizer on different types of bacteria and viruses.

Clearing confusion
San Antonio Express-News - May 23, 2020
Emily Volk, MD, MBA, FCAP, explains COVID-19 antibody testing in this letter to the editor.

Placenta Injury Observed in Pregnant Women Who Test Positive For Coronavirus
Forbes - May 22, 2020
Jeffrey Goldstein, MD, FCAP, is the lead author of a new study from Northwestern University that found "there might be something clot-forming about coronavirus, and it’s happening in the placenta."

UMMC reaches milestone: 10,000 COVID-19 tests and counting
The Clarion-Ledger - May 22, 2020
Timothy Allen, MD, JD, FCAP, discusses his team's approach to creating an in-house COVID-19 test at the University of Mississippi Medical Center.

Blood Shortage Looms in U.S.
Medpage Today - May 21, 2020
Glenn Ramsey, MD, FCAP, chair of the CAP Transfusion, Apheresis, and Cellular Therapy Committee, discusses the effect of the COVID-19 pandemic on the US blood supply and donors.

Valley doctor says not all coronavirus test sites are ‘legit’
KRGV.com - May 21, 2020
Ravindra Veeramachaneni, MD, FCAP, explains legitimate testing sites for COVID-19, which are officially recognized by the county governments in Texas.

Mayo Clinic doctors find many COVID-19 antibody tests fail their quality standards: ABC News exclusive
ABC News - Go.com - May 21, 2020
William Morice, MD, PhD, FCAP, comments on the rushed development and vetting process of COVID-19 antibody tests that may be leading to an increase in unreliable tests on the market.

10 things to know about COVID-19 testing
MD Anderson Cancer Center - May 21, 2020
Micah Bhatti, MD, PhD, FCAP, discusses how COVID-19 testing works, the reliability of at-home tests, and more.

OHSU working toward reliable antibody test
KATU - May 21, 2020
Donna Hansel, MD, PhD, FCAP, discusses antibody test development at Oregon Health and Science University as well as some concerns she has about the tests currently available including how patients understand them.

What You Need to Know About Coronavirus Testing
US News & World Report - May 20, 2020
CAP President Patrick Godbey, MD, FCAP, speaks on behalf of the CAP regarding COVID-19 testing, including the role of antibody testing. convalescent plasma donors, and testing supply shortages.

COVID-19 data chief claims she was fired for refusing to “manipulate data” to back reopening Florida
Salon.com - May 19, 2020
Stephen Nelson, MD, FCAP, comments on claims that Florida officials pressured health care professionals to manipulate numbers related to COVID-19 cases and deaths: "This is no different than any other public record we deal with," he said. "It's paid for by taxpayer dollars, and the taxpayers have a right to know."

How COVID-19 Deaths Are Counted
Scientific American - May 19, 2020
Sally Aiken, MD, FCAP, discusses how medical examiners confirm COVID-19 deaths when cause of death isn't always clear and how the practice supports accurate death counts.

What Tests for COVID-19 Antibodies Can and Can’t Tell Us About the Disease
Healthline - May 14, 2020
Sheldon Campbell, MD, PhD, FCAP, discusses shortcomings of currently available COVID-19 antigen tests

What to Know About Coronavirus Testing
WebMD - May 14, 2020
Gary Procop, MD, MS, FCAP, discusses a study that compared the results and accuracy of five COVID-19 tests and the potential harm caused by false negatives.

How Much Testing Does the U.S. Need to Reopen?
The New Yorker - May 14, 2020
Brian Jackson, MD, FCAP, says that financial uncertainty is one of the major constraints holding back the US testing capacity for COVID-19.

CAP outlines limits of coronavirus serology tests
LabPulse.com - May 13, 2020
In a statement from CAP President Patrick Godbey, MD, FCAP, the CAP detailed its position on current serology testing, reiterating it is no substitute for nucleic acid tests for making a diagnosis.

Gov. Abbott Said 25,000 COVID-19 Tests By Mid-May. Will That Happen?
KERA News - May 12, 2020
Joe Saad, MD, FCAP, discusses shortages in COVID-19 testing supplies including reagents and viral transport media, the latter of which his laboratory began making on its own.

Labs absorb revenue losses, adapt to a 'new normal'
LabPulse.com - May 11, 2020
CAP President Patrick Godbey, MD, FCAP; President-Elect Emily Volk, MD, MBA, FCAP; and Jonathan Myles, MD, FCAP, chair of the Council on Government and Professional Affairs discuss the findings of the CAP's survey of US laboratory directors.

SARS-CoV-2 Testing Problems Started Early; US Still Playing From Behind
360Dx - May 11, 2020
CAP President-Elect Emily Volk, MD, MBA, FCAP, discusses COVID-19 testing and how it has improved despite early setbacks. Jordan Laser, MD, FCAP, also comments.
The article also appeared in Modern Healthcare.

COVID-19 test shortages persist in Illinois, crimping plans for return to normal
ABC7Chicago.com - May 7, 2020
In this TV interview, Patrick Godbey, MD, FCAP, comments on the results of the CAP laboratory survey that showed COVID-19 testing supply shortages in the majority of US laboratories. Karen Kaul, MD, PhD, FCAP, also comments on her laboratory's testing experience.

California's race to conduct as many as 80,000 covid-19 tests every day
MIT Technology Review - May 5, 2020
Christina Kong, MD, FCAP, discusses how laboratories in California are handling COVID-19 testing demand and supply shortages.

VERIFY: Are doctors inaccurately reporting deaths as COVID-19-related
CBS 19 - May 4, 2020
John Wayne, MD, FCAP, explains how death certificates are completed including guidelines for recording COVID-19 deaths.

The Search Is On for America’s Earliest Coronavirus Deaths
The Wall Street Journal - May 4, 2020
James Gill, MD, FCAP, discusses how COVID-19 deaths are identified and what may hamper investigators looking for early cases.

Keeping Pace with the Pandemic
The Pathologist - May 4, 2020
Marisa Saint Martin, MD, FCAP, writes about the importance of mindfulness and meditation during times of crisis and how she has found purpose through her work as a pathologist.

Letters: ‘I do not intend to go to movie theaters, restaurants’
Houston Chronicle - May 4, 2020
In this letter to the editor, Abdul Abid, MD, MBBS, CAP Junior Member and member of the CAP Engaged Leaders Network, explains the essential role of pathologists during the pandemic.

Newsviews: Dr. Karen Kaul
ABC7Chicago.com - May 3, 2020
Karen Kaul, MD, PhD, FCAP, discusses the NorthShore University HealthSystem early COVID-19 test development and their implementation of antibody testing.

Team effort makes free COVID-19 testing site in southwest Little Rock a success
Thv11.com - May 2, 2020
Jennifer Hunt, MD, FCAP, member of the CAP Engaged Leaders Network, oversaw a drive-through COVID-19 testing site organized by the University of Arkansas for Medical Sciences.

AMP, CAP, Others Request Medicare Coverage for Respiratory Panel Tests
360Dx - April 30, 2020
The CAP, along with five other medical organizations, submitted a letter to the Centers for Medicare and Medicaid Services advocating for national coverage for multiplex respiratory viral panel tests.

CDC: Coronavirus and other causes behind increase in deaths in U.S.
NBCNEWS.com - April 30, 2020
Sally Aiken, MD, FCAP, and James Gill, MD, FCAP, comment on tracking the number of deaths linked to COVID-19 and recommend saving samples of the deceased for future testing when more supplies are available.

Autopsies provide crucial information for fighting COVID-19
Popular Science - April 30, 2020
Alex Williamson, MD, FCAP, member of the CAP's Autopsy Committee, discusses the crucial role of medical examiners and autopsies in learning more about COVID-19.

Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19
The JAMA Network - April 30, 2020
Beth Shaz, MD, FCAP, discusses the effectiveness of convalescent plasma treatment for COVID-19.

Oh! So THAT’s what a pathologist does during the coronavirus pandemic
Miami Herald - April 29, 2020
Khaled Algashaamy, MD, CAP Junior Member, and member of the Engaged Leaders Network, authored this article that highlights and explains the role of pathologists during a pandemic while detailing how the laboratories at the University of Miami developed and implemented COVID-19 testing.

How accurate is the US coronavirus death count? Some experts say it's off by 'tens of thousands'
ABC News - Go.com - April 29, 2020
On behalf of the CAP, Alex Williamson, MD, FCAP, comments on the need for more testing to determine the overall impact of the COVID-19 pandemic.

Chicago doctor who treated coronavirus in Wuhan says lessons learned offer hope for Illinois
ABC7Chicago.com - April 28, 2020
Shu-Yuan Xiao, MD, FCAP, recounts his experience in Wuhan at the outbreak of COVID-19 and comments on the spread of the disease in the US and Chicago where he works at the University of Chicago.

Telepathology: Part 2 -- Putting plans into action
LabPulse.com - April 27, 2020
Jesus Chavez, MD, CAP Junior Member; Zoltan Laszik, MD, PhD, FCAP; and Giovanni Lujan, MD, FCAP, discuss the successes and challenges of working remotely and how best to implement digital pathology.

Pathologists Hunt for Earlier Coronavirus Cases in New York
The Wall Street Journal - April 27, 2020
Alain Borczuk, MD, FCAP, and his team at Weill Cornell Medicine are trying to determine if deaths before March in New York might have been initially undetected COVID-19 cases.

1,000 Boston residents to be randomly tested for COVID-19 antibodies in hard-hit neighborhoods
WHDH-TV - April 27, 2020
David Louis, MD, FCAP, says randomized COVID-19 testing in Boston “will also give us information on things like whether someone is ready to go back to work potentially, and it will also give us information on understanding what it means to be immune.”

Telepathology: Part 1 -- COVID-19 gives home working a push
LabPulse.com - April 26, 2020
Eric Glassy, MD, FCAP, discusses effective digital pathology practice for those pathologists working remotely after the temporary waiver from the federal government.

Questions about COVID-19 tests persist in Crossroads, across county
Victoria Advocate - April 25, 2020
Leilani Valdes, MD, FCAP, chair of the CAP Professional and Community Engagement Committee and member of the Engaged Leaders Network, discusses the effectiveness and limitations of COVID-19 testing.

Utah And New Mexico Lead The Region In COVID-19 Testing. Here's How They've Done It
KUNC - April 24, 2020
Richard Scanlan, MD, FCAP, chair of the CAP Council on Accreditation, comments on the relative success of COVID-19 testing at laboratories in Utah and New Mexico.

1 in 5 New Yorkers May Have Had Covid-19, Antibody Tests Suggest
The New York Times - April 23, 2020
Joan Cangiarella, MD, FCAP, is skeptical about the effectiveness of antibody testing, saying more data is needed to determine effectiveness and immunity to COVID-19.

Liron Pantanowitz: The importance of digital pathology
Pittsburgh Post-Gazette - April 23, 2020
In this letter to the editor, Liron Pantanowitz, MD, FCAP, explains the essential role of pathologists during the COVID-19 pandemic as well as the importance of reliable digital pathology systems.

Letter: Laboratory professionals dedicated to fighting virus
St. Louis Post-Dispatch - April 23, 2020
In light of National Medical Laboratory Professionals Week, Christopher O’Conor, MD, PhD, CAP Junior Member, authored this letter to the editor highlighting pathologists, laboratory professionals, and the essential work they do in the laboratory during the COVID-19 pandemic.

At-home testing kits for COVID-19 may soon be hitting the market
WFXT FOX Boston 25 News - April 23, 2020
In this TV interview, Michael Misialek, MD, FCAP, explains COVID-19 at-home testing and antibody testing, and whether the presence of antibodies in a patient indicates immunity.

FDA approves at-home COVID-19 test
UPI.com - April 21, 2020
Bobbi Pritt, MD, FCAP, explains a new FDA approved at-home COVID-19 test.

F.D.A. Approves First In-Home Test for Coronavirus
The New York Times - April 21, 2020
Sheldon Campbell, MD, PhD, FCAP, comments on in-home COVID-19 testing and how it could help patients with mobility difficulties and support telemedicine initiatives.

What will it take to have adequate virus testing?
WCAX-TV CBS - April 21, 2020
Christina Wojewoda, MD, FCAP, explains the COVID-19 testing process at University of Vermont Medical Center, the sensitivity of different tests, and supply shortages.

Letters to the Editor - Lab technicians
The Dallas Morning News - April 19, 2020
Assad Joe Saad, MD, FCAP, and member of the CAP's Engaged Leaders Network, authored this letter to the editor that explains laboratory testing and highlights the role of the pathologist during the COVID-19 pandemic and National Medical Laboratory Professionals Week.

The unsung heroes of the coronavirus battle: laboratory technicians
Hartford Courant - April 18, 2020
Sheldon Campbell, MD, PhD, FCAP, coauthored this article that highlights the essential role of laboratory professionals, especially during the COVID-19 pandemic.

Test troubles cloud Trump recovery effort
PBS NewsHour - April 17, 2020
Meghan Delaney, DO, MPH, FCAP, comments on the shortage of reagents that is hampering COVID-19 testing efforts in her laboratory at Children's National Hospital.

Rapid coronavirus test, commonly used in US, may miss infections in some situations
CNBC - April 16, 2020
Michael Misialek, MD, FCAP, discusses the reported shortcomings and overall effectiveness of the new rapid coronavirus test.

Last responders: The grim job of medical examiners in the COVID-19 pandemic
ABC News - Go.com - April 16, 2020
Angela N. Baldwin, MD, CAP Junior Member, authored this piece profiling the role of medical examiners during a pandemic.

Coronavirus tests for antibodies coming, but public health experts question accuracy
ABC7Chicago.com - April 15, 2020
Karen Kaul, MD, PhD, FCAP, discusses serological tests, their reliability, and their accuracy.

Antibody Tests For Coronavirus Can Miss The Mark
National Public Radio - April 15, 2020
Jordan Laser, MD, FCAP, comments on the usefulness and specificity of new antibody tests to determine patients' COVID-19 immune status.

Daily virtual lectures meet pathology residents where they are
LabPulse.com - April 14, 2020
Christina Arnold, MD, FCAP, discusses the CAP's free online lecture series geared toward pathology residents who may be missing educational opportunities due to the pandemic.

Test makers, FDA struggling with shift from molecular to serology testing for SARS-CoV-2
BioWorld - April 14, 2020
Christina Wojewoda, MD, FCAP, discusses the viability of serology testing in assessing the current and future spread of the COVID-19 pandemic.

Dr. Marc Siegel takes rapid COVID-19 test live on 'Tucker Carlson Tonight'
Fox News - April 13, 2020
Michael Misialek, MD, FCAP, conducts a rapid COVID-19 test on medical correspondent Marc Siegel, MD, during a live interview on the cable news network.

Delayed coronavirus test results strain Washington’s resources and leave patients in limbo
The Seattle Times - April 8, 2020
Eric Konnick, MD, MS, FCAP, comments on the difference in test cost among various types of laboratories.

Coronavirus deaths may be undercounted in Alabama, doctors say
AL.com - April 8, 2020
Randy Hanzlick, MD, FCAP, provides background on autopsies, cause of death, and death certificates and how those might affect tracking COVID-19 deaths.

White House Adviser Kudlow: Looking to reopen economy as soon as health experts give green light
Yahoo! Finance - April 7, 2020
Roger Klein, MD, JD, FCAP, discusses COVID-19 testing, the spread of the pandemic, and implications on the duration of the crisis in this video interview.

Delays and Shortages Exacerbate Coronavirus Testing Gaps in the U.S.
The New York Times - April 7, 2020
Elaine Cham, MD, FCAP, discusses her laboratory's experience with COVID-19 testing and some of the challenges brought about by supply shortages and long turnaround times.

Shortage of Test Components Forces Labs to Beg, Borrow and Improvise
MSN.com - April 5, 2020
Joan Cangiarella, MD, FCAP, discusses how the laboratory at NYU Langone Health is obtaining necessary laboratory testing materials

Lab workers are unseen warriors fighting the coronavirus
ABC News - Go.com - April 4, 2020
Timothy Allen, MD, JD, FCAP, and Kathleen Beavis, MD, FCAP, speak on behalf of the CAP when discussing the essential work being done by pathologists and laboratory professionals during the COVID-19 pandemic. CAP Junior Member Angela Baldwin, MD, authored the article.

Cook County medical examiner searching for warehouse as it braces for more coronavirus deaths. ‘We want to treat the deceased with the respect they deserve’
Chicago Tribune - April 1, 2020
Sally Aiken, MD, FCAP, comments on autopsy guidelines and best practices in light of an increased demand during the COVID-19 pandemic.

'This Is Truly a Last Resort.' Makers Are 3D Printing Ventilator Parts and Sewing Masks Amid a Critical Shortage in Medical Supplies
Time Magazine - April 1, 2020
Guillermo Tearney, MD, PhD, FCAP, is part of a team investigating alternative supplies in preparation for shortages during the COVID-19 pandemic.

Performing the coronavirus test: ‘a tennis ball that doesn’t bounce straight’
Arkansas Times - March 31, 2020
Jennifer Hunt, MD, FCAP, explains how COVID-19 testing works, including some of the challenges laboratories are facing.

Post-Op HPV Vaccine Cuts Cervical Precancer Recurrences
Medpage Today - March 31, 2020
Cornelia Trimble, MD, FCAP, comments on the effectiveness of HPV vaccines after patients have undergone surgery for high-grade cervical intraepithelial neoplasia.

Cambridge biotech seeks OK for coronavirus test that delivers results in 15 minutes
The Boston Globe - March 31, 2020
David Louis, MD, FCAP, comments on newly developed rapid tests for COVID-19.

More on stimulus' health tech boosts
Politico - March 30, 2020
Coverage of the CAP's advocacy work with CMS for a temporary waiver giving pathologists the flexibility needed to work remotely during the COVID-19 pandemic.

Labs scrambling to test for COVID-19 face same obstacle: Not enough supplies
The Buffalo News - March 30, 2020
John Tomaszewski, MD, FCAP, discusses the shortage of testing supplies facing many laboratories.

UMMC begins in-house testing for COVID-19
WJTV News Channel 12 - March 27, 2020
Timothy Allen, MD, JD, FCAP, discusses the University of Mississippi Medical Center (UMMC) laboratory's COVID-19 testing validation and implementation.

Some Chicagoans report lengthy delays on coronavirus test results: More than a week later, ‘I still have nothing’
The Chicago Tribune - March 27, 2020
Karen Kaul, MD, PhD, FCAP, describes the process for COVID-19 testing at NorthShore University HealthSystem.

Cough, Fever, Fatigue? Head to CDC's Online Coronavirus Symptom Checker
US News & World Report - March 27, 2020
Gary Procop, MD, FCAP, comments on the usefulness of the CDC's online coronavirus symptom tracker in helping to alleviate hospital overcrowding and manage patients.

Promising new 15-minute test for coronavirus comes with caveats
ABC News - March 26, 2020
Bobbi Pritt, MD, FCAP, explains the types of testing being done for COVID-19 as well as test development and availability. The article is authored by Angela Baldwin, MD, CAP Junior Member, and a member of the ABC News Medical Unit.

Mayo shifts into overdrive: 24 hours a day, 4,000 tests and climbing
PostBulletin.com - March 25, 2020
Bobbi Pritt, MD, FCAP, discusses the challenges faced by laboratories and health care professionals during the COVID-19 pandemic, as well as Mayo Clinic's efforts to increase testing.

Start-Ups Jump the Gun on Home Kits for Coronavirus Testing
The New York Times - March 23, 2020
Sheldon Campbell, MD, PhD, FCAP, voices concern over direct-to-consumer tests for COVID-19.

The standard coronavirus test, if available, works well—but can new diagnostics help in this pandemic?
Science - March 22, 2020
Benjamin Pinsky, MD, PhD, FCAP, comments on supply shortages and other issues laboratories are facing with COVID-19 testing.

Inside the South Korean Labs Churning Out Coronavirus Tests
The Wall Street Journal - March 19, 2020
Alex Greninger, MD, PhD, FCAP, comments on his University of Washington laboratory's rush to find live virus samples when developing COVID-19 tests before the disease began spreading in the region.

So far, so good for pregnant women with SARS-CoV-2
LabPulse.com - March 19, 2020
Further coverage of a new study in the CAP's Archives of Pathology & Laboratory Medicine, authored by David A. Schwartz, MD, FCAP. that found no apparent transfer of COVID-19 between mother and fetus.

What to know about social distancing strategies amid coronavirus outbreak
ABC13.com - March 19, 2020
Angela Baldwin, MD, CAP Junior Member, member of the ABC News Medical Unit, answers common questions and explains effective social distancing in relation to COVID-19.

How Washington Failed to Build a Robust Coronavirus Testing System
The Wall Street Journal - March 18, 2020
Richard Scanlan, MD, FCAP, comments on the high demand and supply for COVID-19 testing.

Infants Born to Mothers With COVID-19 Appear Healthy
Medscape - March 17, 2020
The CAP's Archives of Pathology & Laboratory Medicine will publish an analysis of pregnant women with COVID-19 and the health of their infants, authored by David A. Schwartz, MD. FCAP.

WGN News at Ten
WGN - March 17, 2020
Karen Kaul, MD, PhD, FCAP, discusses COVID-19 test development, criteria, turnaround time, and supplies after her team at NorthShore University HealthSystem implemented testing. Watch the interview.

Testing criteria for COVID-19 is critical
WIBW 13 News - March 17, 2020
Richard Gomez, MD, FCAP, discusses the criteria for COVID-19 testing considering patients' risk, exposure, and condition.

Coronavirus Test Developed, And Available, At Evanston Hospital, With Results In Just Hours
CBS Chicago - March 16, 2020
Karen Kaul, MD, PhD, FCAP, discusses the rapid development and implementation of COVID-19 testing at NorthShore University HealthSystem.

For Patients

The CAP provides this easy to view table: Clarifying Tests for COVID-19

The CDC provides information related to the prevention and treatment of COVID-19.

Learn more about pathologists and their critical role on the health care team.

For Media

For inquiries related to laboratory medicine and the pathologists’ role in COVID-19, please contact media@cap.org.